Templeman Thomas 4
4 · Centessa Pharmaceuticals plc · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Templeman Thomas
Chief Technology Officer
Transactions
- Award
Share Option (right to buy)
2022-02-01+140,000→ 140,000 totalExercise: $9.53Exp: 2032-02-01→ Ordinary Shares (140,000 underlying)
Footnotes (2)
- [F1]11,664 shares subject to such option shall vest and become exercisable on June 1,2022 and the remaining 128,336 shares subject to such option shall vest and become exercisable in 44 substantially equal installments on each monthly anniversary thereafter.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.